This has certainly been a year unlike any other for BioHealth Capital Region (BHCR) life science companies of all sizes and kinds. Just a few months into 2020, the coronavirus pandemic swept the region, seriously disrupting, albeit temporarily, the best laid plans of aspiring founders, entrepreneurs, emerging startups, pre-clinical and more established, larger biohealth organizations in Virginia, Washington, D.C. and Maryland.
Vigene Biosciences Appoints Audrey Chang, Ph.D. as VP of QC and Analytical Services
2020 Life Science Venture Capital Funding Roundup for Q1/Q2 in the BioHealth Capital Region BioHealth Companies raised more than $178M in the first half of 2020 June 9, 2020 This [….]
Why Batten Hope Foundation is Funding Gene Therapy Clinical Trials for Children with Rare Diseases To hear Gina Hann speak about her son Joseph’s battle with an ultra-rare form of [….]
Vigene Biosciences Grand opening for CDMO Gene Therapy Facility in Maryland